Erin Wilfong, MD, PhD

Erin Wilfong, MD, PhD, is trained in both rheumatology and pulmonary/critical care medicine. Her clinical practice and research are focused on immune-related interstitial lung disease. 

Her laboratory aims to understand immune dysregulation in the idiopathic inflammatory using mass cytometry and single cell transcriptomics. She is also the principal investigator for the Myositis and Scleroderma Treatment Initiative Center (MYSTIC) Cohort and biorepository. She is currently funded by a K08 and a Myositis Association Pilot Award. Dr. Wilfong's clinical interest is in myositis related interstitial lung disease and life threatening rheumatic disease.